Accetto Utilizziamo cookies per migliorare il nostro servizio e realizzare statistiche. Questa funzione puó essere disattivata cambiando la configurazione del browser. Continuando a navigare senza modificare questi parametri, consideriamo che l’uso di cookies sia accettato
Cyclohexanemethylamine was used in the synthesis of Schiff?s base ligand, 4-methyl-2,6-bis(cyclohexylmethyliminomethyl)-phenol, which forms hexanuclear zinc(II) complexes. It was used during the synthesis of 1-acyl-4 cycloalkyl/arylsemicarbazides and 1-acyl-5-benzyloxy/hydroxyl carbamoylcarbazides from the nonsteroidal anti-inflammatory drugs.
Partha Roy; Mario Manassero; Koushik Dhara; Pradyot Banerjee. Synthesis, characterization and fluorescence properties of hexanuclear zinc(II) complexes. Polyhedron. 2009, 28,(6), 1133-1137.
I.Perkovic; I.Butula; M.Kralj; I.Martin-Kleiner; J.Balzarini; D.Hadjipavlou-Litina; A.M.Katsori; B.Zorc. Novel NSAID 1-acyl-4-cycloalkyl/arylsemicarbazides and 1-acyl-5-benzyloxy/hydroxy carbamoylcarbazides as potential anticancer agents and antioxidants. European Journal of Medicinal Chemistry. 2012, 51,227-238.
Dichiarazioni di rischio (UE): H226-H314-H318
Flammable liquid and vapour. Causes severe skin burns and eye damage. Causes serious eye damage.
Dichiarazioni precauzionali: P260u-P201-P280a-P304+P340-P405-P501a
Obtain special instructions before use. Wear protective gloves and eye/face protection. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.